Dr. Pamela Merino, MD

Dr. Merino practices at Vitalmd Group Holding in South Miami, Florida.

Dr. Merino's NPI, 1124054234, was assigned on June 23, 2006. Dr. Merino graduated from Universidad Nacional Pedro Henriquez Urena in 1991. Dr. Merino holds Florida license ME91134.

Dr. Merino's primary practice is Vitalmd Group Holding, at 6705 Red Rd, South Miami, FL 33143 in Miami-Dade County. The practice phone is (305) 273-4641.

Dr. Merino's primary practice is Vitalmd Group Holding in South Miami, Florida. Dr. Merino is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is VitalMD. Dmand AI also links Dr. Merino to 3 more hospitals, 2 physician offices and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merino practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Merino's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Merino is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Merino's licenses on file in 2 states: Florida and Connecticut.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute sinusitis, acute skin infection, alcohol use disorders, alzheimer's disease, anxiety and arthritis among the conditions Dr. Merino treats.

CMS data shows 1,344 Medicare services from Dr. Merino across 13 procedure codes in 2024, for 230 Medicare patients. Medicare paid $101,877 for them. Every service was in an office.

CMS counts 230 Medicare patients who saw Dr. Merino in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Merino's median patient age at 56, with 73% women.

In 2024, Dr. Merino wrote 2,391 Medicare Part D claims for 311 patients. 84% of them were for generic drugs. CMS names the drug for 1,793 of them, across 55 drugs with 11 or more claims each, at $215,027 in total drug cost. In 2023, CMS named 1,750 claims across 53 drugs.

Dr. Merino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Merino as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 406 general payments to Dr. Merino from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novo Nordisk Inc paid the most, $1,407.

Dmand AI lists 1 award for Dr. Merino, most recently CMS Stage 1 EHR in 2013.

Dr. Merino graduated from Universidad Nacional Pedro Henriquez Urena in 1991.

Dr. Merino is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.